Literature DB >> 12963924

Malignant Langerhans cell tumor: a case with a favorable outcome associated with the absence of blood dendritic cell proliferation.

Laurent Misery1, William Godard, Hind Hamzeh, Véronique Lévigne, Claude Vincent, Jean-Luc Perrot, Anne Gentil-Perret, Daniel Schmitt, Frédéric Cambazard.   

Abstract

Malignant Langerhans cell tumor is a rare malignant proliferation of Langerhans cells, with a negative prognosis due to its dissemination throughout the body, leading to death within 1 year. This disease has to be distinguished from Langerhans cell histiocytosis. The favorable evolution of a case of Langerhans cell tumor, characterized by the absence of metastasis 18 months after its occurrence, may be due to the initial treatment, which consisted of complete and large resection of the tumor. The authors searched for abnormal dendritic cells or progenitors in the blood but found no large amounts or proliferation of CD34(+) or CD1a(+) cells at the diagnosis and 1 year later. This case report shows that malignant Langerhans cell tumor is not always a lethal disease. The condition may be related to surgical treatment and the absence of malignant cells in the blood when the diagnosis was performed.

Entities:  

Mesh:

Year:  2003        PMID: 12963924     DOI: 10.1067/s0190-9622(03)00450-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

Review 1.  Cutaneous Langerhans cell sarcoma: a case report and review of the literature.

Authors:  Olga L Bohn; Guillermo Ruiz-Argüelles; Leticia Navarro; Jesus Saldivar; Sergio Sanchez-Sosa
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

2.  Langerhans cell sarcoma arising from Langerhans cell histiocytosis: a case report.

Authors:  Jong-Sil Lee; Gyung Hyuck Ko; Ho Cheol Kim; In Seok Jang; Kyung-Nyeo Jeon; Jeong-Hee Lee
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

3.  ESHAP therapy effective in a patient with Langerhans cell sarcoma.

Authors:  Akihide Yoshimi; Keiki Kumano; Toru Motokura; Yutaka Takazawa; Satoshi Oota; Shigeru Chiba; Tsuyoshi Takahashi; Masashi Fukayama; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2008-04-17       Impact factor: 2.490

4.  Diagnostic value of Wilms tumor 1 and CD44 in Langerhans cell sarcoma: case series of 4 patients.

Authors:  Chang-song Wang; Yan-ping Chen; Wei-hua He; Jian Yin; Chun-fang Gao; Ping Wang; Hong Li; Xue-xia Lv
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

5.  Langerhans Cell Sarcoma of the Axillary Lymph Node: A Case Report and Review of the Literature.

Authors:  Aylin Orgen Çallı; Yelda Morgül; İnci Alacacıoğlu; Sadi Bener; Bahriye Payzin
Journal:  Turk J Haematol       Date:  2013-06-05       Impact factor: 1.831

6.  Langerhans cell sarcoma originating from left knee subcutaneous tissue: A case report and literature review.

Authors:  Yaonan Zhang; Zongyang Qu; Fang Fang
Journal:  Oncol Lett       Date:  2016-09-27       Impact factor: 2.967

7.  Unusual cutaneous Langerhans cell sarcoma without extracutaneous involvement.

Authors:  Yang Li; Bin Li; Xiao-ying Tian; Zhi Li
Journal:  Diagn Pathol       Date:  2013-02-06       Impact factor: 2.644

8.  Epstein-Barr Virus-Positive Langerhans Cell Sarcoma: Is There a Link? A Case Report.

Authors:  Yu Guo; Shui-Hong Zhou; Zai-Zai Cao; Yang-Yang Bao; Li-Fang Shen; Hong-Tian Yao
Journal:  Front Oncol       Date:  2022-01-18       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.